Menopause and the Estrobolome: What Research Shows About Estrogen and Symptoms

Quick Answer: What is the estrobolome, and how does it relate to menopause?

The estrobolome is the set of gut bacterial genes whose products can metabolize and recycle estrogens. Certain gut microbes make enzymes, including beta-glucuronidase, that can reactivate conjugated estrogens in the gut so they are reabsorbed rather than excreted. Menopause is primarily an endocrine transition, driven by the decline of ovarian hormones, and the gut microbiome interacts with that transition rather than causing it. A large human study found that menopause status is associated with a shifted gut microbiome and a lower abundance of the estrobolome enzyme, but whether these microbial differences drive hot flashes, mood changes, or sleep problems is not established. So the honest position is that the estrobolome is one contributor worth understanding, supporting gut health through diet and lifestyle is reasonable, and no supplement is a treatment for menopause. Decisions about hormone therapy or symptom treatment belong with a healthcare professional.

Menopause is often discussed only as a drop in estrogen, and that decline is indeed the central event. What is increasingly studied is how the gut microbiome interacts with estrogen, and the clearest point of contact is the estrobolome. This article explains what the estrobolome is, what the research does and does not show about its role during menopause, and where gut-focused habits reasonably fit. It builds on our pillar guide on hormones, the microbiome, and women's gut health, and complements our look at perimenopause and gut health.

Explore the Complete Menopause Science Hub

This article is part of a broader, science-based resource on menopause as a whole-body transition involving hormones, the gut, sleep, and metabolism. For the structured overview of all related articles, visit the Menopause and Gut Health science hub.

What Is the Estrobolome?

The estrobolome is the collection of enteric bacterial genes whose products are capable of metabolizing estrogens. That precise definition comes from Claudia Plottel and Martin Blaser, who introduced the concept in a review on the microbiome and cancer risk (Plottel 2011, review). It is a functional set of microbial genes, not simply a group of bacteria.

The mechanism works through estrogen recycling. The liver conjugates estrogens (attaches molecules that mark them for excretion) and sends them into the gut through bile. There, microbes with the right enzymes, principally beta-glucuronidase, and other deconjugating and metabolizing activities, can remove those tags, allowing some estrogen to be reabsorbed into circulation (Baker 2017, review). Beta-glucuronidase is the best-known enzyme in this process, but it is not the whole story; a range of microbial enzymes and pathways contribute.

After menopause, microbial deconjugation may become one contributor to how conjugated estrogens are reactivated and recirculated. It is important to keep this in perspective: systemic estrogen availability is determined by multiple endocrine and metabolic processes, including production in fat and other tissues, protein binding, and receptor activity. The estrobolome is one input, not the controller of estrogen levels.

What Might the Estrobolome Influence?

It helps to sort what is genuinely supported from what is still being investigated.

Supported mechanism

• Microbial deconjugation and recycling of estrogens in the gut (established biology).

Human associations (observed, not proven to be causal)

• Menopause status is associated with a shifted gut microbiome and estrobolome.

• Menopause-related microbiome differences have been linked to cardiometabolic markers.

• Gut microbiome features correlate with sex-hormone metabolites.

Not yet established

• Direct control of hot flashes.

• Direct treatment of insomnia.

• Direct control of mood symptoms.

Researchers are investigating whether differences in estrobolome function contribute to some of the person-to-person variation seen during menopause. This has not yet been established as a clinical explanation for symptom severity, so it is best described as a promising research question rather than a settled fact.

How Menopause Relates to the Gut Microbiome

The strongest human evidence here comes from a large study in the Hispanic Community Health Study and Study of Latinos, which used shotgun metagenomic sequencing on stool from 2,300 people (295 premenopausal women, 1,027 postmenopausal women, and 978 men). Postmenopausal women trended toward lower gut microbiome diversity and an altered overall composition compared with premenopausal women, and their microbiome looked more like that of men, which the authors interpreted as consistent with the loss of female hormones. The estrobolome enzyme beta-glucuronidase was lower after menopause, and these differences were associated with cardiometabolic markers (Peters 2022, human).

Two cautions keep this accurate. First, it is cross-sectional, so it shows association, not cause. Second, the popular claim that "menopause lowers microbiome diversity" is not a clean rule: this large study found a trend, and smaller studies have reported inconsistent results, partly because the healthy microbiome varies so much by region, diet, and lifestyle (He 2018, human). The fair summary is that menopause is associated with measurable microbiome change, and the details are still being worked out.

What Is Established versus What Is Proposed

A quick guide to where the science stands.

Menopause, Metabolism, and the Microbiome

Weight and metabolic shifts are common around menopause, and they are driven mainly by changes in hormones, muscle mass, activity, and aging. The gut microbiome is one of the factors studied in relation to metabolism and weight, including insulin sensitivity and inflammatory tone, and menopause-related microbiome differences have been associated with less favorable cardiometabolic profiles (Peters 2022). These are associations rather than proof that the microbiome causes menopausal weight gain, and stress, sleep, and appetite can overlap with all of this.

On the practical side, the evidence for probiotics changing weight in this group is mixed and product-specific. For example, a 12-week trial of a Lactobacillus acidophilus strain in postmenopausal women reduced body fat but was also associated with a rise in glucose (Kim 2024, human trial). That is a reason for measured expectations, not sweeping claims.

Sleep, Daily Rhythms, and the Microbiome

Gut microbes show daily oscillations that interact with host feeding and circadian rhythms (Thaiss 2014, animal), and sleep and the microbiome influence each other. Since sleep is often disrupted around menopause, this is a reasonable area of interest, though the evidence that microbial rhythm changes worsen menopause symptoms specifically is not established. For the detail, see our circadian rhythm and gut microbiome guide.

How the Microbiome Fits Alongside Hormone Therapy

Menopausal hormone therapy is an evidence-based medical option that can effectively reduce many symptoms, and whether it is right for a given person is a decision to make with a clinician, weighing benefits and individual risks. Nothing about the microbiome changes that.

Supporting gut health through diet and lifestyle is a sensible part of general wellbeing during menopause, and it can sit alongside medical care. What the evidence does not support is presenting the microbiome as the missing piece that hormone therapy fails to address, or suggesting that gut issues make hormone therapy fall short. The two are not in competition, and gut-focused habits are a complement to, not a substitute for, appropriate medical treatment.

Frequently Asked Questions About Menopause and the Estrobolome

1. How does the gut microbiome relate to menopause symptoms?

The microbiome interacts with estrogen through the estrobolome, the set of bacterial genes that help recycle estrogens in the gut. Menopause is associated with a shifted microbiome, but whether these microbial changes drive specific symptoms like hot flashes or mood changes is not established. The microbiome is one contributor worth understanding, not a proven cause of symptom severity.

2. What is the estrobolome and why does it matter?

The estrobolome is the collection of gut bacterial genes whose products metabolize and recycle estrogens. It matters because, through enzymes like beta-glucuronidase, gut microbes can influence how much conjugated estrogen is reactivated and reabsorbed. It is one input into estrogen physiology, alongside hormone production, binding, and receptor activity.

3. Can gut health affect hot flashes and sleep during menopause?

It is an active research question rather than a settled fact. Menopause is associated with microbiome and sleep changes, and the systems interact, but there is no established evidence that fixing the microbiome directly reduces hot flashes or treats insomnia. If hot flashes or sleep problems affect your life, discuss evidence-based options with a clinician.

4. Is menopause weight gain caused by the gut microbiome?

Not primarily. Weight and metabolic changes around menopause are driven mainly by hormones, muscle loss, activity, and aging. The microbiome is associated with metabolic markers and may be one contributing factor, but it is not the main cause, and probiotic effects on weight in this group are mixed and product-specific.

5. Can microbiome health change after menopause?

Yes. The gut microbiome remains dynamic and responds to diet, activity, sleep, and other lifestyle factors throughout life. Supporting it is reasonable for general health, though changing the microbiome is not a proven way to treat menopause symptoms.

6. How do I fix my estrobolome?

There is no validated protocol to fix or reset the estrobolome, and it is not something you can measure or correct in a targeted way at home. The sensible, evidence-aligned approach is to support gut health broadly: a varied, fiber-rich diet, fermented foods if tolerated, regular activity and sleep, and limited alcohol. These support microbial diversity generally rather than tuning a single enzyme pathway.

7. Is there an estrobolome probiotic?

No probiotic has been shown to reliably "restore" the estrobolome or to treat menopause symptoms through it. Some probiotics have shown mixed, product-specific effects on metabolic markers in menopausal women, but that is different from correcting estrogen metabolism. Be cautious of products marketed as estrobolome fixes; the science does not yet support that claim. It is also worth knowing that more beta-glucuronidase activity is not automatically better, since higher estrogen reactivation has been studied in the context of estrogen-driven conditions, so the goal is balance, not simply more of one enzyme.

Scientific References

1. Plottel CS, Blaser MJ.
   Microbiome and malignancy
   Cell Host and Microbe 2011;10(4):324-335 
   doi:10.1016/j.chom.2011.10.003 (Review; introduced the estrobolome concept)

2. Baker JM, Al-Nakkash L, Herbst-Kralovetz MM.
   Estrogen-gut microbiome axis: physiological and clinical implications
   Maturitas 2017;103:45-53
   doi:10.1016/j.maturitas.2017.06.025 (Review)

3. Peters BA, Lin J, Qi Q, et al.
   Menopause Is Associated with an Altered Gut Microbiome and Estrobolome, with Implications for Adverse Cardiometabolic Risk in the Hispanic Community Health Study/Study of Latinos
   mSystems 2022;7(3):e0027322
   doi:10.1128/msystems.00273-22 (Large human cross-sectional study, n=2,300)

4. He Y, Wu W, Zheng HM, et al.
   Regional variation limits applications of healthy gut microbiome reference ranges and disease models
   Nature Medicine 2018;24(10):1532-1535
   doi:10.1038/s41591-018-0164-x (Human study; microbiome variation by region)

5. Thaiss CA, Zeevi D, Levy M, et al.
   Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis
   Cell 2014;159(3):514-529 
   doi:10.1016/j.cell.2014.09.048 (Animal study)

6. Kim H, et al.
   Effects of daily probiotic supplementation with Lactobacillus acidophilus on calcium status, bone metabolism biomarkers, and bone mineral density in postmenopausal women
   Frontiers in Nutrition 2024;11:1401920 
   doi:10.3389/fnut.2024.1401920 (Human randomized trial in postmenopausal women)

7. Depommier C, Everard A, Druart C, et al.
   Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
   Nature Medicine 2019;25(7):1096-1103
   doi:10.1038/s41591-019-0495-2 (Human randomized pilot; metabolic markers)

Written by Ali Rıza Akın

Microbiome Scientist, Author & Founder of Next-Microbiome

Ali Rıza Akın is a microbiome scientist with nearly 30 years of experience in translational biotechnology, systems biology, and applied microbiome research, spanning discovery, preclinical development, and clinical-stage translation.

His work focuses on how microbial ecosystems interact with human physiology, including:

• Gut barrier function and intestinal permeability

• Mucus-associated microbiota (Akkermansia-related systems)

• Oral–gut microbiome axis

• Short-chain fatty acids (SCFAs) and metabolic signaling

• Circadian rhythm–microbiome interactions

• Clinical Research Contributions

He has contributed to multiple clinical-stage microbiome programs, supporting bacterial strain discovery, optimization, and formulation design across different therapeutic areas, including:

Active Ulcerative Colitis (Inflammatory Bowel Disease)

Hyperoxaluria (Oxalate Metabolism Disorder)

Microbiome-driven gut health and inflammatory conditions

These studies were part of broader clinical development programs evaluating microbiome-based approaches. His contributions focused on the early-stage scientific and translational pipeline, including strain discovery, functional optimization, and multi-strain formulation design.

Scientific Contributions:

Ali Rıza Akın is the discoverer of Christensenella californii, a bacterial species associated with microbiome diversity and metabolic health.

He is a contributing author to scientific publications and Bacterial Therapy of Cancer (Springer), and the author of Bakterin Kadar Yaşa: İçimizdeki Evren: Mikrobiyotamız.

Approach:

His work emphasizes evidence-based microbiome science, long-term safety, and a systems-based understanding of how microbes influence human health.

Review and Sources

This article is written and reviewed by a microbiome scientist and is based on the peer-reviewed studies listed in the References. Established biology, human associations, and areas that are not yet established are labeled throughout, so readers can weigh each claim. It is reviewed periodically against current research.

Medical Disclaimer

This content is for educational and informational purposes only and is not medical advice. It does not diagnose, treat, cure, or prevent any disease or condition, including menopausal symptoms such as hot flashes, mood changes, or insomnia. Dietary supplements, including Akkermansia and herbal menopause products, are not a treatment for menopause and are not a substitute for medical care or for menopausal hormone therapy. Decisions about hormone therapy or symptom treatment should be made with a qualified healthcare professional. Consult your clinician before starting any new supplement, especially if you are pregnant, nursing, managing a health condition, taking medication, or considering hormone therapy.

Last reviewed: August 2026